Similar Items: Generation of recombinant SNAP-tag based antibody fusion proteins for immunotherapy of acute myeloid leukemia (AML)
- The experiences of caregives caring for children diagnosed with acute leukemia
- Design and validation of molecular diagnostic assays for key prognostic biomarkers, FLT3-ITD, NPM1, DNMT3A and CEBPA in cytogenetically normal aml patients at Tygerberg Hospital, South Africa
- Imatinib resistance : the role of pharmacogenetic variability in a South African chronic myeloid leukemia cohort
- Developing novel SNAP tag-based antibody fusion proteins directionally conjugated to fluorophores for immunophenotyping of acute myeloid leukemia
- Establishment of recombinant antibody technologies allowing for the generation of SNAP-tag fusion proteins
- Screening and characterisation of BCR::ABL1 kinase domain mutations in chronic myeloid leukaemia participants at Tygerberg Hospital, South Africa
Author: Barth, Stefan
- Evaluation of tumour-associated antigens to optically label cutaneous basal cell carcinoma for surgical excision
- Establishment of enhanced protein purification strategies for recombinant immunotherapeutics
- Generation of Glioblastoma specific SNAP based antibody fusion proteins for future radiolabelling application
- Development and Characterization of recombinant immunotoxins for cervical carcinoma
- Development of potential immunodiagnostic & therapeutic techniques using SNAP-fusion proteins as tools for the validation of Triple-negative Breast Cancer
- Comparison of the therapeutic efficacy of SNAP-tag fusion protein and the synergistic actions of chemotherapy and photodynamic therapy in killing resistant melanoma